- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00609908
The Technique of Skin Stretching for Acute Burn Treatment and Scar Reconstruction
The Technique of Skin Stretching for Acute Burn Treatment and Scar Reconstruction: Clinical Applications and Working Mechanisms.
Objective:
A randomized controlled trial is performed to evaluate the clinical effectiveness of the skin stretching technique for two categories:
- acute burn wounds: wound closure by means of skin stretching should lead to a significant reduction of scar surface area in comparison to the standard technique, the split skin grafting;
- scar reconstructions: wound closure by means of skin stretching during one operative procedure should lead to a comparable scar surface in comparison to the multiple procedures techniques such as serial excision.
Study design:
Skin stretching will be compared to split skin grafting and should result in burn wound closure with significantly smaller scars. Also, a comparison will be made between the technique of serial excision versus skin stretching for scar reconstructions.
Scar evaluation three and twelve months after surgery will include the following parameters:
- surface area;
- Patient and Observer Scar Assessment Scale (POSAS);
- elasticity;
- vascularization and pigmentation;
- thickness;
- dermal architecture.
After 12 months adults will undergo a biopsy of the scar under local anesthesia. The experimental group, treated with the skin stretcher will undergo one extra biopsy of the formerly stretched skin.
Intervention:
At the start of the operation will be determined by randomization if skin stretching or split skin grafting (acute burn wounds) or serial excision (scar reconstruction category) will be performed.
Study Overview
Status
Detailed Description
Eligibility criteria:
Inclusion:
1. Acute Burn wounds or scar reconstructions that require surgical treatment; 2. Sufficient healthy skin at (at least) one edge of the wound/scar must be available for the stretching procedure.
3. Age >= 18 years
Exclusion:
- language barrier;
- known history of keloid formation;
- systemic diseases: Diabetes Mellitus, immunodeficiency, arterial insufficiency;
- local or systemic application of corticosteroids;
- psychiatric diseases leading to study bias (e.g. automutilation);
- skin diseases that lead to collagen and/or elastin abnormalities such as Ehlers Danlos;
- radiated skin;
- wound located at extremities, exceeding >33% of circumference (acute burn category);
Primary study parameters/outcome of the study:
The primary study parameter is the surface area of the scar after 12 months
Secondary study parameters/outcome of the study (if applicable):
All scars will also be subjected to the scar evaluation protocol after 3 and 12 months by an independent observer for the evaluation of the:
- patient and observer scar assessment scale (POSAS);
- scar elasticity (Cutometer);
- scar vascularisation & pigmentation (DermaSpectrometer);
- scar thickness (histopathology, only after 12 months).
Punch biopsies are taken for morphometry of dermal architecture (Fourier analysis). During surgery one biopsy is obtained of the normal skin. In the experimental group an additional biopsy is obtained at the end of the stretching procedure in order to be able to compare structure of the dermal matrix and orientation of the collagen fibers.
After 1 year, one biopsy is taken from the scar. The experimental group will undergo one additional biopsy of the formerly stretched skin.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Beverwijk, Netherlands
- Red Cross Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- Acute Burn wounds or scar reconstructions that require surgical treatment;
- Sufficient healthy skin at (at least) one edge of the wound/scar must be available for the stretching procedure;
- Age >= 18 years.
Exclusion criteria:
- Language barrier;
- Known history of keloid formation;
- Systemic diseases: Diabetes Mellitus, immunodeficiency, arterial insufficiency;
- Local or systemic application of corticosteroids;
- Psychiatric diseases leading to study bias (e.g. automutilation);
- Skin diseases that lead to collagen and/or elastin abnormalities such as Ehlers Danlos;
- Radiated skin;
- Wound located at extremities, exceeding >33% of circumference (acute burn category).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: A1
Acute Burn Wounds: Wound debridement and split skin grafting
|
After wound bed preparation the skin defect is covered with a skin transplant (split skin graft)
|
Experimental: A2
Acute Burn Wounds: excision of the burn wound and primary closure, using a skin stretching device
|
after woundbed preparation the wound is primarily closed by aid of the skin stretching device
after the scar is excised, the wound is primarily closed by aid of the skin stretching device
|
Active Comparator: B1
Scar reconstruction: serial excision
|
as much scar as possible is excised, whereafter the wound is closed
|
Experimental: B2
Scar reconstruction: primary closure, using skin stretching device
|
after woundbed preparation the wound is primarily closed by aid of the skin stretching device
after the scar is excised, the wound is primarily closed by aid of the skin stretching device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the surface area of the scar after 12 months
Time Frame: 3 and 12 months after surgery
|
3 and 12 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
scar evaluation protocol: - patient and observer scar assessment scale (POSAS); - scar elasticity (Cutometer); - scar vascularization & pigmentation (DermaSpectrometer); - scar thickness
Time Frame: 3 and 12 months after surgery
|
3 and 12 months after surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: E Middelkoop, Professor, VU MC
- Study Director: P.P.M. van Zuijlen, MD, PhD, Red Cross Hospital Beverwijk
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 06.201
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burns
-
American Scitech InternationalJohnson & JohnsonUnknownBurns | Electric BurnsUnited States
-
MediWound LtdUnknownBurns, Upper Extremity | Burns, Lower ExtremitySlovakia
-
Singapore General HospitalUnknownAcute Thermal BurnsSingapore
-
RenovaCare, IncActive, not recruitingBurns | Burns Second Degree | Burns Deep Second DegreeUnited States
-
MediWound LtdCompletedThermal BurnsUnited States, Israel, Belgium, Czechia, Georgia, Germany, Italy, Romania
-
Sun Yat-sen UniversityCompleted
-
MediWound LtdActive, not recruitingThermal BurnsUnited States, United Kingdom, Spain, Georgia, Belgium, Poland, Germany, Hungary, India, Italy, Netherlands, Romania, Slovakia, Ukraine
-
Virginia Commonwealth UniversityNot yet recruiting
-
The Hong Kong Polytechnic UniversityCompleted
-
St. Justine's HospitalRecruiting
Clinical Trials on Split skin graft
-
Markman Biologics CorporationUnknown
-
University Hospital, GhentDutch Burnwound Foundation, NetherlandCompletedFull Thickness Skin DefectsBelgium
-
Indonesia UniversityRecruitingBurn Degree Second | Burn Degree ThirdIndonesia
-
Avita MedicalUnited States Department of Defense; Royal Perth Hospital; MedDRA Assistance Inc and other collaboratorsCompleted
-
First Affiliated Hospital, Sun Yat-Sen UniversityRecruiting
-
Assiut UniversityWithdrawn
-
Coordinación de Investigación en Salud, MexicoUnknownBurns | Skin UlcerMexico
-
CUTISS AGUniversity of Zurich; University Hospital, Zürich; Julius Clinical; Sintesi Research... and other collaboratorsRecruitingBurnsSwitzerland, Italy, Netherlands
-
CUTISS AGUniversity of Zurich; University Hospital, Zürich; Julius Clinical; Sintesi Research... and other collaboratorsActive, not recruitingBurnsSwitzerland, Netherlands, Italy
-
CUTISS AGUniversity of Zurich; University Hospital, Zürich; Julius Clinical; Sintesi Research... and other collaboratorsActive, not recruitingSkin WoundSwitzerland, Italy, Netherlands